An open-label pilot trial found that a single fecal microbiota transplantation cleared adherent-invasive E. coli from the gut ...
A 2025 survey of NHS employees highlighted worrying variations in awareness of C difficile infection, risk factors and ...
New clinical data show omilancor reduced a molecular signature associated with biologic refractoriness by more than 55% in ulcerative colitis and Crohn’s disease patients. Omila ...
Resplice Autism Research Foundation & Institute has opened its second Faecal Microbiota Transplantation (FMT) Centre in India ...
Executing a full strategic portfolio reset, RedHill is now a stronger commercial entity with Rebyota® and Clenpiq®, two established FDA-approved gastrointestinal (GI) ...
WashU Medicine researchers have been awarded a nearly $11 million grant from the National Institute of Allergy and Infectious ...
An antibiotic resistance gene helps a dangerous gut bacterium build tougher spores that can survive hospital disinfectants.
The placebo rate was 33% versus 70% anticipated, limiting statistical power; larger studies may further assess protection ...
AI is accelerating antibiotic discovery, but clinical translation requires standardized data, safety optimization, and new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results